Exclusive Q&A: FDA’s principal deputy commissioner on taking over for Califf, adcomms, accelerated approvals and more

With a new pres­i­den­tial ad­min­is­tra­tion next year, FDA Prin­ci­pal Deputy Com­mis­sion­er Na­mand­jé Bum­pus would be in line to lead the agency if cur­rent Com­mis­sion­er Robert …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.